Related Experiment Video
Updated: May 20, 2026
08:20
Systematic Approach to Identify Novel Antimicrobial and Antibiofilm Molecules from Plants' Extracts and Fractions to Prevent Dental Caries
Published on: March 31, 2021
Looking for new targets: simple coumarins as antibacterial agents
Maria João Matos1, Saleta Vazquez-Rodriguez, Lourdes Santana
1Departamento de Química Orgánica, Facultad de Farmacia, Universidad de Santiago de Compostela, 15782, Santiago de Compostela, Spain. mariacmatos@gmail.com
Medicinal Chemistry (Shariqah (United Arab Emirates))
|July 12, 2012
Summary
New antimicrobial drug discovery is crucial due to rising resistant infections. Simple 3-aminocoumarin derivatives show promising antibacterial activity against E. coli and S. aureus, with effectiveness depending on molecular structure.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Antimicrobial Research
Background:
- Increasing global prevalence of drug-resistant and multi-drug-resistant microbial infections necessitates novel therapeutic strategies.
- Existing antimicrobial agents are insufficient, highlighting the urgent need for innovative drug candidates.
- Medicinal Chemistry plays a vital role in identifying new molecules to combat resistant pathogens.
Purpose of the Study:
- To synthesize and evaluate a series of 3-aminocoumarin derivatives for antimicrobial properties.
- To investigate the antibacterial and antifungal activities of these compounds against key clinical isolates.
- To conduct a preliminary structure-activity relationship (SAR) study to understand the impact of substitutions on efficacy.
Main Methods:
- Synthesis of various 3-aminocoumarin compounds, including unsubstituted and substituted variants (methyl, methoxy groups).
- Evaluation of synthesized compounds against clinical isolates of Staphylococcus aureus, Escherichia coli, and Candida albicans.
- Preliminary SAR analysis to correlate structural modifications with observed antimicrobial activity.
Main Results:
- Several synthesized 3-aminocoumarin derivatives demonstrated significant antibacterial activity.
- Activity was observed against both Gram-positive (Staphylococcus aureus) and Gram-negative (Escherichia coli) bacteria.
- The study indicated that the antibacterial efficacy against E. coli and S. aureus is influenced by the type and position of substituents on the coumarin ring.
Conclusions:
- Structurally simple 3-aminocoumarins represent a potential scaffold for developing new antibacterial agents.
- The substitution pattern on the coumarin moiety is critical for determining antibacterial potency and spectrum.
- Further research into these coumarin derivatives could lead to novel treatments for resistant bacterial infections.
Related Concept Videos
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
00:57Antibiotic Selection
Overview
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...